About POC Pharma
POC Pharma is a company based in Hong Kong (China) founded in 2005 by Charles Defrance. POC Pharma has raised $14.8 million across 3 funding rounds from investors including FJ Labs, Alven and Picus Capital. POC Pharma offers products and services including POP Data and Analytics Solutions. POC Pharma operates in a competitive market with competitors including Pharmapod, CerpassRx, Amplicare, Asepha and CPS Solutions, among others.
- Headquarter Hong Kong, China
- Founders Charles Defrance
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Poc Company Limited
-
Annual Revenue
$34.2 M (USD)46as on Dec 31, 2023
-
Net Profit
$9.11 M (USD)73as on Dec 31, 2023
-
EBITDA
$10.09 M (USD)60as on Dec 31, 2023
-
Total Equity Funding
$14.8 M (USD)
in 3 rounds
-
Latest Funding Round
$10.3 M (USD), Series A
Apr 20, 2022
-
Investors
FJ Labs
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of POC Pharma
POC Pharma offers a comprehensive portfolio of products and services, including POP Data and Analytics Solutions.
Provides sales and behavioral insights from retail pharmacies.
Offers KPIs for measuring market shares and sales drivers.
People of POC Pharma
Unlock access to complete
Leadership Team
1 people
Product Management Team
1 people
Southeast Team
1 people
Africa Team
1 people
Unlock access to complete
Funding Insights of POC Pharma
POC Pharma has successfully raised a total of $14.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.3 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.3M
-
First Round
First Round
(28 Feb 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series A - POC Pharma | Valuation | Alven | |
| Apr, 2021 | Amount | Series A - POC Pharma | Valuation |
investors |
|
| Feb, 2019 | Amount | Grant - POC Pharma | Valuation |
investors |
Investors in POC Pharma
POC Pharma has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include FJ Labs, Alven and Picus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are targeted by Alven, a venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early stage healthcare, renewable energy, real estate, finance, and multiple businesses
|
Founded Year | Domain | Location | |
|
Early-stage investments in tech startups are managed by the fund.
|
Founded Year | Domain | Location |
Investments & Acquisitions by POC Pharma
Financial Statements - POC Pharma
Poc Pharma Comparisons
Competitors of POC Pharma
POC Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmapod, CerpassRx, Amplicare, Asepha and CPS Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based application for pharmacists to record and share medication-related incidents
|
|
| domain | founded_year | HQ Location |
Digital platform for pharmacies and members for pharmacy benefit management
|
|
| domain | founded_year | HQ Location |
Decision automation platform for pharmacies is developed to streamline operations.
|
|
| domain | founded_year | HQ Location |
AI-driven tools for pharmacy automation and patient personalization are offered.
|
|
| domain | founded_year | HQ Location |
Provider of pharmacy management, telepharmacy, and specialty pharmacy software solutions
|
Frequently Asked Questions about POC Pharma
POC Pharma was founded in 2005 and raised its 1st funding round 14 years after it was founded.
POC Pharma is headquartered in Hong Kong, China.
POC Pharma is a funded company, having raised a total of $14.8M across 3 funding rounds to date. The company's 1st funding round was a Grant of $56.9K, raised on Feb 28, 2019.
Annual revenue of POC Pharma is $34.2M as on Dec 31, 2023.
POC Pharma was founded in 2005 in Hong Kong, China, within the healthcare technology sector. Digital tools for pharmacy management are offered, supporting operations through features such as order placement, stock data sharing, telecommunication integration, and cloud-based marketing. Daily workflows in pharmacies are streamlined by these solutions, enabling efficient data handling and communication across locations.
POC Pharma offers POP Data and Analytics Solutions.
POC Pharma has 7 investors. Key investors include FJ Labs, Alven, Picus Capital, FEBE Ventures, and Goat Capital.